Descriptor English: | Proto-Oncogene Proteins c-bcl-6 | ||||||
Descriptor Spanish: |
Proteínas Proto-Oncogénicas c-bcl-6
| ||||||
Descriptor Portuguese: | Proteínas Proto-Oncogênicas c-bcl-6 | ||||||
Descriptor French: | Protéines proto-oncogènes c-bcl-6 | ||||||
Entry term(s): |
B Cell Lymphoma 6 Protein B-Cell Lymphoma 6 Protein Proto Oncogene Protein bcl 6 Proto Oncogene Protein c bcl 6 Proto Oncogene Proteins c bcl 6 Proto-Oncogene Protein bcl-6 Proto-Oncogene Protein c-bcl-6 Proto-Oncogene Proteins, bcl-6 Proto-Oncogene Proteins, c-bcl-6 Zinc Finger Protein 51 bcl 6 Proto Oncogene Proteins bcl-6 Proto-Oncogene Proteins bcl-6, Proto-Oncogene Protein c bcl 6 Protein c bcl 6 Proto Oncogene Proteins c-bcl-6 Protein c-bcl-6 Proto-Oncogene Proteins c-bcl-6, Proto-Oncogene Proteins |
||||||
Tree number(s): |
D12.776.260.660 D12.776.624.664.700.170 D12.776.930.715 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D051560 | ||||||
Scope note: | A DNA-binding protein that contains an N-terminal BTB (POZ) DOMAIN and C-terminal CYS2-HIS2 ZINC FINGERS. It represses GENETIC TRANSCRIPTION of target genes by recruiting HISTONE DEACETYLASES. Aberrant Blc-6 expression is associated with certain types of human B-CELL LYMPHOMA. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Public MeSH Note: | 2006; PROTO-ONCOGENE PROTEIN C-BCL-6 was indexed under DNA-BINDING PROTEINS & PROTO-ONCOGENE PROTEINS & TRANSCRIPTION FACTORS 1993-2005 |
||||||
History Note: | 2006(1993) |
||||||
DeCS ID: | 51045 | ||||||
Unique ID: | D051560 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2006/01/01 | ||||||
Date of Entry: | 2005/06/30 | ||||||
Revision Date: | 2016/04/15 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Proto-Oncogene Proteins c-bcl-6
- Preferred
Concept UI |
M0222844 |
Scope note | A DNA-binding protein that contains an N-terminal BTB (POZ) DOMAIN and C-terminal CYS2-HIS2 ZINC FINGERS. It represses GENETIC TRANSCRIPTION of target genes by recruiting HISTONE DEACETYLASES. Aberrant Blc-6 expression is associated with certain types of human B-CELL LYMPHOMA. |
Preferred term | Proto-Oncogene Proteins c-bcl-6 |
Entry term(s) |
B Cell Lymphoma 6 Protein B-Cell Lymphoma 6 Protein Proto Oncogene Protein bcl 6 Proto Oncogene Protein c bcl 6 Proto Oncogene Proteins c bcl 6 Proto-Oncogene Protein bcl-6 Proto-Oncogene Protein c-bcl-6 Proto-Oncogene Proteins, bcl-6 Proto-Oncogene Proteins, c-bcl-6 Zinc Finger Protein 51 bcl 6 Proto Oncogene Proteins bcl-6 Proto-Oncogene Proteins bcl-6, Proto-Oncogene Protein c bcl 6 Protein c bcl 6 Proto Oncogene Proteins c-bcl-6 Protein c-bcl-6 Proto-Oncogene Proteins c-bcl-6, Proto-Oncogene Proteins |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey